Tuesday, December 10, 2013

Biosensors Int'l : BIG belief leads to BIG value (CIMB)

Biosensors Int'l
Current S$0.95
Target S$1.19
BIG belief leads to BIG value

We see bright spots in Spectrum Dynamics’s instant success and the positives that regulatory approvals and new launches could bring. A change in its major shareholder from a strategic one to a value-driven one augurs well for BIG.

Under our revised rating structure, our call changes from Outperform to Add. Our EPS and SOP-based target price are unchanged. Our contrarian Add rating hinges on the instant success Spectrum Dynamics, product launches, regulatory approvals and M&A accretion. More importantly, new shareholder, CITIC, could seek to enhance its investment value through more active participation.


CITIC’s involvement
Investors can look forward to CITIC as the new shareholder at the start of 2014. Positives that could surface: 1) CITIC will play a more active role, not just in managing BIG‟s operations but also in strategic direction, from M&As to corporate finance. 2) While BIG‟s earnings has been dragged down by weaker contributions from Japan‟s licensing income, BIG‟s objective is to obtain SFDA approval for BioFreedom in China and to add other accretive acquisitions. As this is the forte of private-equity funds, we believe CITIC‟s involvement will work in BIG‟s favour. 3) CITIC‟s choice of owning BIG could be an endorsement of the latter‟s leadership in stent-making and intention to be a serious medical-platform contender, potentially setting BIG apart from the rest of its Asian peers, including Terumo. 4) A privatisation of BIG could even be possible if its current two private-equity shareholders want to rejig the company.

Sources of excitement
Additionally, Spectrum Dynamics will boost earnings when it gets approval from China‟s Food and Drug Administration. BIG is working on multiple product launches to generate new revenues. Other products are gaining ground with various regulatory approvals and the soft launch of BioFreedom remains a source of excitement.

Contrarian positive view
We think BIG‟s cheaper valuation only prices in the near-term challenges and understates the earnings uplift from the commercialisation of new products in FY15.




Source/Extract/Excerpts/来源/转贴/摘录: CIMB-Research,
Publish date: 29/11/13

No comments:

Post a Comment

Warren E. Buffett(沃伦•巴菲特)
Be fearful when others are greedy, and be greedy when others are fearful
别人贪婪时我恐惧, 别人恐惧时我贪婪
投资只需学好两门课: 一,是如何给企业估值,二,是如何看待股市波动
吉姆·罗杰斯(Jim Rogers)
“错过时机”胜于“搞错对象”:不会全军覆没!”
做自己熟悉的事,等到发现大好机会才投钱下去

乔治·索罗斯(George Soros)

“犯错误并没有什么好羞耻的,只有知错不改才是耻辱。”

如果操作过量,即使对市场判断正确,仍会一败涂地。

李驰(中国巴菲特)
高估期间, 卖对, 不卖也对, 买是错的。
低估期间, 买对, 不买也是对, 卖是错的。

Tan Teng Boo


There’s no such thing as defensive stocks.Every stock can be defensive depending on what price you pay for it and what value you get,
冷眼(冯时能)投资概念
“买股票就是买公司的股份,买股份就是与陌生人合股做生意”。
合股做生意,则公司股份的业绩高于一切,而股票的价值决定于盈利。
价值是本,价格是末,故公司比股市重要百倍。
曹仁超-香港股神/港股明灯
1.有智慧,不如趁势
2.止损不止盈
成功者所以成功,是因为不怕失败!失败者所以失败,是失败后不再尝试!
曾淵滄-散户明灯
每逢灾难就是机会,而是在灾难发生时贱价买股票,然后放在一边,耐性地等灾难结束
  • Selected Indexes 52 week range

  • Margin of Safety

    Investment Clock

    World's First Interactive Investment Clock